◆ 会议时间：2025年10月17-21日
◆ 会议地点：德国 柏林

◆ 会议简介：

2025年欧洲肿瘤内科学会(ESMO)年会/大会将于2025年10月17-21日在德国柏林举行，会议由欧洲肿瘤内科学会(ESMO)主办。欧洲肿瘤内科学会年会(ESMO大会)是欧洲最负盛名和最具影响力的肿瘤学会议，每年都有超过30,000名专业人士参加会议；届时来自世界各地的临床医生、研究人员、患者倡导者、记者和制药业人士将齐聚一堂，一起分享了解肿瘤学领域的最新进展，并将科学转化为最佳的癌症患者护理。ESMO大会科学计划将由一个300多名国际专家组成的委员会制定，内容涵盖从基础研究到癌症免疫治疗的最新发现，从肿瘤护理到姑息治疗，从罕见癌症到药物批准，等等。ESMO年度大会将成为转化研究、呈现实践变化数据宣和多学科讨论的卓越全球平台，大会将提供优秀的科学教育计划，为代表们提供了丰富的交流意见的机会。（2020ESMO虚拟年会数字：30000余名与会者来自150多个国家/地区；230余位演讲嘉宾；2137份摘要提交）

欧洲肿瘤内科学会（ESMO）成立于1975年，是全球领先的肿瘤内科学专业组织。ESMO是肿瘤学教育和信息的参考学会，现在全球160多个国家和地区拥有超过25,000余名会员；ESMO致力于通过宣促进多学科的癌症护理，支持肿瘤学家的专业发展以及在全球倡导可持续的癌症护理，尽而为癌症患者提供最佳的护理。未经本站许可，禁止复制转载摘录镜像本站任何内容-领域国际医学会议网(lingyuint.com)。

ESMO 2025 - European Society of Medical Oncology (ESMO) Congress 2025

Date: 17-21 October 2025
Venue: Messe Berlin (Berlin, Germany)

The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. 

ESMO 2025 will be a place where groundbreaking discoveries, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care.

You will be able to learn from internationally renowned experts, engage in thought-provoking discussions and connect with fellow oncology professionals that are driving advancements in diagnosis, treatment and survivorship.

Save the date for ESMO 2025, taking place in Berlin, Germany 17-21 October 2025.

摘要征文投稿：

Abstract submission deadlines-征稿截止日期

Abstract submission deadlines

点此提交摘要>>>Submit Abstract>>>

• ESMO Congress 2025 Abstract Regulations

Abstract submission categories

• Basic science
• Biliary tract cancer, incl. cholangiocarcinoma
• Biomarkers and translational research (agnostic)
• Breast cancer, early stage
• Breast cancer, locally advanced
• Breast cancer, metastatic
• CNS tumours
• Colorectal cancer
• Developmental therapeutics
• Endocrine tumours
• Germ cell (testicular) cancer and penile cancer
• Gynaecological cancers
• Haematological malignancies
• Head and neck cancer, excluding thyroid
• Hepatocellular carcinoma (HCC)
• Investigational immunotherapy
• Melanoma and other skin tumours
• Miscellaneous
• Neuroendocrine tumours
• New diagnostic tools
• NSCLC, early stage
• NSCLC, locally advanced
• NSCLC, metastatic
• Oesophagogastric cancer 
• Palliative care
• Pancreatic cancer
• Policy
• Prostate cancer
• Psycho-oncology
• Renal cancer
• Sarcoma
• SCLC
• Supportive care
• Thoracic malignancies, other
• Thyroid cancer
• Tumour biology and pathology
• Urothelial cancer
• *Cancer Nursing: Advance care planning and palliative care
• *Cancer Nursing: eHealth and digital innovations
• *Cancer Nursing: Health promotion, prevention and screening
• *Cancer Nursing: Leadership and educational issues in cancer nursing
• *Cancer Nursing: Precision health
• *Cancer Nursing: Rehabilitation and survivorship care
• *Cancer Nursing: Symptom management

*Abstracts may also be submitted to the Cancer nursing track. Submissions in these categories will be reviewed by the European Oncology Nursing Society (EONS) Scientific Committee for selection and presentation in the EONS cancer nursing programme. Unless otherwise stated, submissions in the Cancer nursing categories must follow all regular ESMO Congress 2025 submission regulations and guidelines.

Late-breaking abstracts (LBAs)

Late-breaking abstracts may be submitted for high quality, new research findings from prospective interventional clinical trials or observational series (large real world data sets) or novel technologies with major implications for clinical practice and/or understanding and targeting of disease processes. 

The final late-breaking abstract deadline of 9 September 2025 is under no circumstances to be considered as an extension of the general submission deadline.

Outcome notifications

Outcome notifications of regular abstracts are expected to be made available to first authors and submitters between 16 and 18 July 2025.

Outcome notifications of pre-accepted, full LBAs are expected to be made available to first authors and submitters between 16 and 18 September 2025.

Abstract presenter registration

The presenting author or the designated replacement presenter must be registered by 1 October 2025. Should the Presenter (or designated replacement presenter) not be registered by the given deadline, the abstract will be excluded from presentation in the ESMO Congress 2025 programme, and removed from the online programme and publication in the ESMO Congress 2025 Abstract Book.

Information for presenters

Detailed instructions for the preparation of slide presentations and posters/ePosters will be made available on the ESMO website by end July 2025 in the “Information for Presenters” section.

Titles of accepted regular abstracts are expected to be made available online in the “Programme” section, by 25 July 2025.

Titles of accepted regular abstracts are expected to be made available online in the “Programme” section, by 20 September 2025.

Presentation and publication of accepted abstracts

The ESMO Congress 2025 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

• Presidential Symposium – Oral presentations by authors presenting cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.

• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.

• Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.

• Poster – Paper poster presentation for review and discussion onsite. Presenting authors must attend the Congress in person to represent their work. Preparation of an e-Poster file is also mandatory for inclusion in the Congress Virtual Platform and onsite digital screens.

• E-Poster – Electronic poster in PDF format for inclusion in the Congress Virtual Platform and onsite digital screens. Presenting authors of ePosters are not required to attend the Congress in person to represent their work. Paper posters are not to be prepared, and poster boards will not be provided.

All accepted abstracts, will be published online in the ESMO Congress 2025 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.

Publication schedule for accepted abstracts

Details regarding the publication of accepted abstracts are available here.

ESMO Merit Travel Grants

A limited number of ESMO Merit Travel Grants to the ESMO Congress 2025 are available, upon application, to first authors (= presenters) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO Congress 2025 Scientific Committee on a competitive basis from among the accepted abstracts.

ESMO2025 注册费：

Registration includes:

• Admission to onsite scientific and educational sessions with the possibility to interact with Speakers, Session Chairs and panel speakers
• Networking opportunities with the congress faculty and peers
• Entry to the poster and e-poster area
• Interaction with industry partners in the trade exhibition 
• Participation in the Industry Satellite Symposia
• Access to the virtual congress platform to watch the sessions live or view the content on-demand
• Post-event resources (webcasts, slides, abstracts) on OncologyPRO

*Applicable to ESMO members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.

** ESMO Members must be under 40 and in training to qualify for this fee.

*** EONS Cancer Nurses must be under 35 to qualify for this fee.

Please send an email to registration@esmo.org to request one of the badges in the "Other registration fees" table above.